By: Alena Wiese

For many healthcare practice owners, peripheral neuropathy is not viewed as a business issue. It’s seen as a clinical challenge—complex, time-consuming, and often frustrating, but firmly in the realm of patient care.

That assumption is quietly changing.

Across outpatient practices nationwide, neuropathy has become one of the more operationally disruptive conditions clinicians encounter. Visits run longer. Explanations are harder. Outcomes are difficult to measure. Patient confidence erodes when symptoms persist without clarity. And when clinicians lack a structured approach, neuropathy cases can destabilize workflows in ways that directly affect growth, retention, and reputation.

This growing realization is why clinic owners and operators are paying attention to Dr. Michael W. Mathesie and the three-hour Neuropathy Deep Dive he is headlining at The Shift Summit, taking place February 21, 2026, in Richardson, Texas.

When a Clinical Gap Becomes an Operational Problem

Peripheral neuropathy is not a niche condition. It affects millions of adults and is commonly associated with diabetes, metabolic disease, medication exposure, and age-related nerve degeneration. As patient populations grow older and more complex, neuropathy-related complaints are becoming increasingly routine across chiropractic, primary care, physical therapy, and regenerative practices.

Yet most clinicians were never trained to manage neuropathy as a repeatable system.

From a business standpoint, this can matter. Neuropathy patients often require:

• Longer appointment times
  
• More extensive explanations
  
• Additional documentation
  
• Greater emotional reassurance
  

Without structure, these cases may introduce friction into otherwise efficient practices. Schedules back up. Staff feel uncertain. Patients disengage when explanations feel vague or inconsistent. Over time, this erodes trust—not just in the clinician, but in the practice itself.

For owners focused on scalability and sustainability, neuropathy becomes a silent risk.

Why “Just Add a Modality” Isn’t the Answer

Many practices attempt to solve neuropathy challenges by adding tools—new technologies, devices, or therapies. While these may have clinical value, they rarely address the underlying issue.

The problem is not a lack of tools.

The problem is a lack of decision-making frameworks.

Without a clear system for evaluating neuropathy, explaining it to patients, and tracking outcomes, even the best modalities may fail to deliver consistent results. Patients don’t comply with plans they don’t understand. Teams struggle to communicate confidently. Owners see variability instead of predictability.

This is where Dr. Mathesie’s work stands out.

A Systems Thinker in a Clinical World

Dr. Michael W. Mathesie is not known for chasing trends. His reputation is built on structure.

As a Certified Laser Practitioner, board-certified rehabilitation specialist (DACRB), and former board member of the Florida Board of Chiropractic Medicine, Dr. Mathesie has spent decades working with complex neurological and pain cases—particularly those that don’t fit neatly into standard models.

What differentiates his approach is not a single technique, but a repeatable clinical reasoning system. He focuses on helping clinicians understand:

• What they are actually seeing neurologically
  
• How to classify neuropathy accurately
  
• How to communicate findings in patient-friendly language
  
• How to make defensible, scope-appropriate decisions
  

For practice owners, this translates into something far more valuable than a new modality: consistent results.

Why Consistency Is the Real Growth Lever

From an operational standpoint, consistency drives everything:

• Predictable visit flow
  
• Clear staff communication
  
• Stronger patient trust
  
• Higher compliance
  
• Reduced provider burnout
  

Neuropathy disrupts all of these when handled without structure.

Dr. Mathesie’s framework addresses neuropathy as a leadership issue within the practice. When clinicians understand how to evaluate and explain neuropathy confidently, patients are more likely to feel guided rather than confused. Teams align around shared language. Documentation becomes clearer. Referrals are intentional rather than reactive.

For owners, this could mean fewer stalled cases and more stable systems.

The Three-Hour Neuropathy Deep Dive at The Shift Summit

At The Shift Summit, Dr. Mathesie will lead a three-hour intensive workshop titled “SHIFT Your Approach to Peripheral Neuropathy for More Effective Outcomes.”

This is not a motivational session or a technique demo. It is designed for practicing clinicians and practice leaders who want clarity they can implement immediately.

The workshop covers:

• Accurate classification of neuropathy (small vs. large fiber; sensory, motor, autonomic)
  
• Focused patient histories that reveal true drivers of symptoms
  
• Clear, repeatable neurological and physical exams
  
• Use of screening tools and Patient-Reported Outcome Measures (PROMs)
  
• Formation of confident clinical impressions
  
• Conservative care planning within scope
  
• Knowing when referral or co-management is appropriate
  

Just as importantly, it teaches clinicians how to explain neuropathy in simple, confidence-building language—a skill that could directly impact patient retention and outcomes.

For owners, this is where the ROI becomes evident.

Why This Matters to Practice Owners and CEOs

Healthcare CEOs and clinic owners are under increasing pressure to deliver better outcomes with fewer resources. Patient expectations are higher. Competition is stronger. Regulatory scrutiny is real.

In this environment, practices cannot afford conditions that drain time, energy, and trust.

Neuropathy, when unmanaged structurally, can do exactly that.

By investing in education that strengthens clinical reasoning and communication—not just tools—owners equip their teams to handle complex cases without destabilizing operations.

That is why The Shift Summit is drawing interest not only from clinicians, but from leaders responsible for scaling practices sustainably.

A Summit Designed for Decision-Makers

While the Neuropathy Deep Dive is a cornerstone of the event, The Shift Summit also brings together leaders in regenerative care, performance, and practice sustainability, including Dr. Robert Hanopole and Dr. Michael Rubenstein, co-founders of ReliefNow® Laser Centers.

The common thread is not hype. It is structure—how to build practices that function reliably under complexity.

The Bottom Line for CEOs

Neuropathy is not just a clinical issue. It is an operational one.

Practices that lack a clear system for handling neuropathy risk longer visits, frustrated staff, disengaged patients, and inconsistent outcomes. Practices that invest in structure stand to gain confidence, clarity, and stability.

Dr. Michael W. Mathesie’s Neuropathy Deep Dive at The Shift Summit represents a strategic opportunity for healthcare leaders who understand that the strongest growth lever is not more volume—but better systems.

The Shift Summit
February 21, 2026
Richardson, Texas
Learn more: https://event.reliefnowlaserdoc.com/theshiftsummit

Disclaimer: The content of this article is intended for informational purposes only and does not constitute medical or professional advice. Always seek the advice of your physician or other qualified healthcare provider regarding any medical condition. The views expressed in this article are those of the author and do not necessarily reflect the views of any associated organization. Practices or treatments mentioned should be discussed with healthcare professionals before being implemented.